HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fethi Guemira Selected Research

NK Cell Lectin-Like Receptor Subfamily K

10/2020MICA-129 Met/Val polymorphism could be a genetic biomarker for Familial Breast Cancer in the Tunisian population.
8/2017MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fethi Guemira Research Topics

Disease

11Neoplasms (Cancer)
10/2020 - 03/2006
6Breast Neoplasms (Breast Cancer)
10/2020 - 06/2008
6Nasopharyngeal Carcinoma
07/2020 - 04/2004
3Colorectal Neoplasms (Colorectal Cancer)
01/2012 - 06/2010
2Ductal Carcinoma
05/2016 - 03/2015
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2016 - 08/2007
2Anemia
04/2007 - 02/2007
1Familial Breast Cancer
10/2020
1Epstein-Barr Virus Infections
04/2013
1Thalassemia
02/2013
1Gastritis
07/2010
1Ovarian Neoplasms (Ovarian Cancer)
06/2008
1Medullary Carcinoma
03/2006
1Thyroid Neoplasms (Thyroid Cancer)
03/2006
1Carcinoma (Carcinomatosis)
04/2004
1Neoplasm Metastasis (Metastasis)
11/2002

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
10/2020 - 11/2002
3micaIBA
10/2020 - 08/2017
3Biological ProductsIBA
07/2010 - 11/2005
2valylvaline (Val-Val)IBA
10/2020 - 08/2017
2NK Cell Lectin-Like Receptor Subfamily KIBA
10/2020 - 08/2017
2AnthracyclinesIBA
05/2016 - 03/2015
2Carcinoembryonic AntigenIBA
01/2012 - 06/2010
2ThyroglobulinFDA Link
06/2008 - 03/2006
2ErythropoietinFDA Link
04/2007 - 02/2007
1AntibodiesIBA
07/2020
13' Untranslated Regions (3' UTR)IBA
07/2019
1HLA-G Antigens (HLA G)IBA
07/2019
1arginylprolineIBA
05/2016
1HLA-E AntigensIBA
04/2016
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
12/2015
1O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA
01/2015
1TransferasesIBA
01/2015
1Glutathione (Reduced Glutathione)IBA
01/2015
1Nitric Oxide Synthase (NO Synthase)IBA
01/2015
1AntioxidantsIBA
01/2015
1MicroRNAs (MicroRNA)IBA
04/2013
1hemoglobin ArabIBA
02/2013
1hemoglobin DIBA
02/2013
1AntigensIBA
01/2012
1LipidsIBA
02/2011
1CholesterolIBA
02/2011
1Oxidoreductases (Dehydrogenase)IBA
06/2010
1C-Reactive ProteinIBA
06/2010
1Viral AntigensIBA
02/2009
1Tumor Biomarkers (Tumor Markers)IBA
06/2008
1Prostate-Specific Antigen (Semenogelase)IBA
06/2008
1Indicators and Reagents (Reagents)IBA
08/2007
1Interleukin-2 Receptor alpha SubunitIBA
08/2007
1N- (8- aminooctyl)- 5- iodonaphthalene- 1- sulfonamideIBA
04/2007
1IronIBA
04/2007
1Hemoglobins (Hemoglobin)IBA
04/2007
1Ferritins (Ferritin)IBA
04/2007
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2006
1antigen CYFRA21.1IBA
04/2004
1Keratin-19 (Keratin 19)IBA
04/2004

Therapy/Procedure

2Drug Therapy (Chemotherapy)
05/2016 - 03/2015
1Aftercare (After-Treatment)
02/2011
1Therapeutics
06/2008
1Preoperative Period
04/2007
1Perioperative Period
04/2007